Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.02. | Punktid Technologies: Delisting from the Stock Exchange | 33 | GlobeNewswire (Europe) | Punktid Technologies AS hereby announces that the stock exchange has initiated supervisory proceedings regarding Punktid Technologies AS, which may result in a sanction, including the potential termination... ► Artikel lesen | |
07.02. | Pliant Therapeutics, Inc.: Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis | 412 | GlobeNewswire (Europe) | Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO... ► Artikel lesen | |
07.02. | Mexco Energy Corp.: Mexco Energy Corporation Reports Financial Results for Third Quarter | 108 | GlobeNewswire (Europe) | MIDLAND, TX, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) today reported net income of $1,077,370, or $0.51 per diluted share, for the nine months ending December... ► Artikel lesen | |
07.02. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 98 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
07.02. | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 87 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives... ► Artikel lesen | |
07.02. | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 154 | GlobeNewswire (Europe) | BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
07.02. | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 100 | GlobeNewswire (Europe) | MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
07.02. | Parks! America, Inc. Reports First Quarter Fiscal Year 2025 Financial Results | 100 | GlobeNewswire (Europe) | Management to host conference call on Monday, February 10, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), today announced its financial... ► Artikel lesen | |
07.02. | Friedman Industries Inc.: Friedman Industries, Incorporated Announces Third Quarter Results | 115 | GlobeNewswire (Europe) | LONGVIEW, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Friedman Industries, Incorporated (NYSE American: FRD) announced today its results of operations for the third fiscal quarter ended December 31,... ► Artikel lesen | |
07.02. | Beyond Oil Ltd.: Beyond Oil Expands into Sweden with 5-Year Distribution Agreement | 454 | GlobeNewswire (Europe) | VANCOUVER, BC and KIBBUTZ YIFAT, Israel, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company... ► Artikel lesen | |
07.02. | Brera Holdings PLC: Brera Holdings Announces Anticipated Receipt of Nasdaq Additional Deficiency Notice | 203 | GlobeNewswire (Europe) | Dublin, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC ("Brera Holdings" or "the Company") (Nasdaq: BREA), an Ireland-based, Nasdaq-listed, international holding company focused on... ► Artikel lesen | |
07.02. | Callan JMB Inc.: Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering | 132 | GlobeNewswire (Europe) | SPRING BRANCH, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency... ► Artikel lesen | |
07.02. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 179 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
07.02. | AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards | 139 | GlobeNewswire (Europe) | IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under... ► Artikel lesen | |
07.02. | Retail Opportunity Investments Corp. Stockholders Approve Acquisition by Blackstone Real Estate | 1.219 | GlobeNewswire (Europe) | SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ: ROIC) ("ROIC" or the "Company") today announced that, at the concluded special meeting of stockholders held... ► Artikel lesen | |
07.02. | Ottawa Bancorp, Inc. Announces Fourth Quarter and Fiscal 2024 Results and 2025 Annual Meeting Date | 117 | GlobeNewswire (Europe) | OTTAWA, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the "Company") (OTCQX: OTTW), the holding company for OSB Community Bank (the "Bank"), announced net income of $0.5 million, or... ► Artikel lesen | |
07.02. | Replimune Group Inc: Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 129 | GlobeNewswire (Europe) | WOBURN, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced... ► Artikel lesen | |
07.02. | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 89 | GlobeNewswire (Europe) | NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company... ► Artikel lesen | |
07.02. | Pharming Group N.V.: Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period | 132 | GlobeNewswire (Europe) | This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation... ► Artikel lesen | |
07.02. | Track Group Reports 1st Quarter Fiscal 2025 Financial Results | 160 | GlobeNewswire (Europe) | NAPERVILLE, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
RHEINMETALL | 5.386 |
RENK GROUP | 4.024 |
NVIDIA | 3.517 |
THYSSENKRUPP | 2.818 |
HENSOLDT | 2.543 |
BYD | 2.472 |
BAYER | 2.134 |
SUPER MICRO COMPUTER | 1.492 |
TESLA | 1.472 |
TUI | 1.185 |
PALANTIR TECHNOLOGIES | 949 |
XIAOMI | 923 |
VOLKSWAGEN | 879 |
COMMERZBANK | 878 |
EVOTEC | 787 |
AIXTRON SE | 777 |
BASF | 776 |
DEUTSCHE TELEKOM | 771 |
MICROSTRATEGY | 759 |
NEL | 738 |
DEUTSCHE BANK | 729 |
ALLIANZ | 704 |
MERCEDES-BENZ | 655 |
NORDEX | 606 |
BAE SYSTEMS | 597 |